AstraZeneca PLC
11806.00
12-September-25 08:29:57
15 minutes delayed
Stocks
-166.00
-1.39%
Today's range
11770.00 - 11988.00
ISIN
N/A
Source
Cboe
-
AstraZeneca's TAGRISSO Combo Delivers Survival Advantage In EGFRm NSCLC Phase III Trial
07 Sep 2025 05:08:13 By NASDAQ US Markets
-
October 3rd Options Now Available For AstraZeneca (AZN)
21 Aug 2025 08:59:57 By NASDAQ Stocks
-
October 3rd Options Now Available For AstraZeneca (AZN)
21 Aug 2025 08:57:26 By NASDAQ US Markets
-
You May Now Give Yourself A Flu Vaccine At Home With FluMist Home
16 Aug 2025 04:08:53 By Forbes - World
-
AstraZeneca Launches FluMist Home For Easy At Home Flu Vaccination
15 Aug 2025 05:31:24 By NASDAQ US Markets
-
Sophia Genetics Expands Partnership With AstraZeneca
05 Aug 2025 10:12:50 By NASDAQ US Markets
-
AstraZeneca’s CFO On The Company’s Bet To Increase Its U.S. Business
05 Aug 2025 09:37:34 By Forbes - World
-
AstraZeneca Q2 Results Climb; Confirms FY25 Outlook
28 Jul 2025 23:46:04 By NASDAQ US Markets
-
Tempus AI or NVIDIA: Which is the Smarter Bet in AI-Backed Healthcare?
28 Jul 2025 11:54:43 By NASDAQ Stocks
-
AZN Crosses Above Key Moving Average Level
23 Jul 2025 09:06:04 By NASDAQ Stocks
-
AstraZeneca To Invest $50 Bln In U.S. By 2030 To Boost Medicine Production And Research
21 Jul 2025 19:36:44 By NASDAQ US Markets
-
AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer
04 Jul 2025 06:53:04 By NASDAQ Stocks
-
AstraZeneca's Imfinzi Approved In EU For Muscle-Invasive Bladder Cancer
03 Jul 2025 23:51:22 By NASDAQ US Markets
-
Why AstraZeneca Stock Got Thumped on Thursday
03 Jul 2025 16:07:30 By NASDAQ US Markets
-
Why AstraZeneca Stock Topped the Market on Tuesday
01 Jul 2025 15:02:48 By NASDAQ US Markets
-
AZN Crosses Above Key Moving Average Level
01 Jul 2025 09:11:29 By NASDAQ Stocks
-
AZN Crosses Above Key Moving Average Level
01 Jul 2025 09:01:25 By NASDAQ US Markets
-
December 19th Options Now Available For AstraZeneca (AZN)
16 Jun 2025 08:05:39 By NASDAQ US Markets
-
December 19th Options Now Available For AstraZeneca (AZN)
16 Jun 2025 07:54:18 By NASDAQ Stocks
-
AstraZeneca: Calquence-based Regimens Approved In EU For Patients With Chronic Lymphocytic Leukaemia
05 Jun 2025 23:38:43 By NASDAQ US Markets
- <<
- <
- 1
- >